A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective.
about
An Additive Effect of Oral N-Acetyl Cysteine on Eradication of Helicobacter pylori.The clinical management of acetaminophen poisoning in a community hospital system: factors associated with hospital length of stayRifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicityCost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity.
P2860
A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@ast
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@en
type
label
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@ast
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@en
prefLabel
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@ast
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@en
P1476
A clinical and pharmacoeconomi ...... tylcysteine: a US perspective.
@en
P2093
Colleen M Culley
Edward P Krenzelok
P2860
P304
P356
10.2165/00139709-200524020-00007
P577
2005-01-01T00:00:00Z
P6179
1017895104